Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma ...

As Frontiers Health 2024 approaches, taking place in Berlin 17th and 18th October, pharmaphorum sat down with one of its ...

The aim is to reverse NICE's decision not to recommend NHS funding in England and Wales for AstraZeneca and Daiichi Sankyo's ...

Our round-up of recent biotech financings features a strong first round for City Therapeutics, a new RNAi venture led by ...

Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...

GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...

Closed Loop Medicine is a TechBio company developing prescription combination drug plus software products, with the aim of ...

In a new webinar, sponsored by PurpleLab, experts explore how PurpleLab's data solutions can help foster a deeper understanding of physician prescribing behaviour. Join us on Tuesday 5th November at ...

The way forward, then, is to deliver truly personalised medicines and care. For industry, this means developing therapies ...

Done right, events can also foster a sense of community. Life as a frontline clinician today can be extremely lonely, but ...

The right partners excel at delivering precise, targeted messages to the right audience segments. This requires deep understanding of the nuances of the healthcare environment and the right skills to ...

Eli Lilly has named Thomas Fuchs as its first-ever chief artificial intelligence officer (CAIO), bolstering the digital ...